- Anheuser-Busch InBev SA/NV BUD reported for the fourth quarter FY22 organic sale Up 10.2% year over year to $14.67 billion, missing consensus of $15.37 billion.
- On an organic basis, total volumes were down 0.6%, with own beer volumes down 0.9% and non-beer volumes up 1.9%. Sales per hl increased by 11.2%.
- The company reported a 6.6% increase in combined sales of its global brands Budweiser, Stella Artois and Corona outside their respective home markets in Q4 ’22.
- Gross profit increased 5.4% organically to $8 billion, and gross margin shrank 249 basis points to 54.6%.
- Normalized EBITDA for the quarter was $4.947 billion, with margin shrinking to 33.7%.
- Underlying earnings per share of $0.86 beat consensus of $0.70.
- The Company’s Board of Directors is proposing a dividend of €0.75 per share for the full year 2022, subject to shareholder approval at the Annual General Meeting on April 26, 2023.
- outlook: Anheuser-Busch InBev expects its EBITDA to grow in line with its mid-term guidance of 4% to 8% and revenue to grow above EBITDA on a healthy combination of volume and price.
- It projects net investments for FY23 of $4.5 billion – 5 billion dollars.
- Price promotion: BUD shares are trading down 2.27% at $58.88 on the last check Thursday premarket.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
[ad_2]
Source story
